Challenges in recombinant brain-derived neurotrophic factor production

ÉF Rodrigues, AL Fachin, M Marins, RG Stabeli… - Trends in …, 2024 - cell.com
Brain-derived neurotrophic factor (BDNF) is a neurotrophin of marked commercial, scientific,
diagnostic, and therapeutic interest. The preservation of its structural cystine-knot is the main …

Measuring the sequence-affinity landscape of antibodies with massively parallel titration curves

RM Adams, T Mora, AM Walczak, JB Kinney - Elife, 2016 - elifesciences.org
Despite the central role that antibodies play in the adaptive immune system and in
biotechnology, much remains unknown about the quantitative relationship between an …

Nanoformulation of brain‐derived neurotrophic factor with target receptor‐triggered‐release in the central nervous system

Y Jiang, JM Fay, CD Poon, N Vinod… - Advanced functional …, 2018 - Wiley Online Library
Brain‐derived neurotrophic factor (BDNF) is identified as a potent neuroprotective and
neuroregenerative agent for many neurological diseases. Regrettably, its delivery to the …

Yeast surface display: new opportunities for a time-tested protein engineering system

M Raeeszadeh-Sarmazdeh, ET Boder - Yeast surface display, 2022 - Springer
Yeast surface display has proven to be a powerful tool for the discovery of antibodies and
other novel binding proteins and for engineering the affinity and selectivity of existing …

Structural insights into VLR fine specificity for blood group carbohydrates

BC Collins, RJ Gunn, TR McKitrick, RD Cummings… - Structure, 2017 - cell.com
High-quality reagents to study and detect glycans with high specificity for research and
clinical applications are severely lacking. Here, we structurally and functionally characterize …

Identification of variable lymphocyte receptors that can target therapeutics to pathologically exposed brain extracellular matrix

BJ Umlauf, PA Clark, JM Lajoie, JV Georgieva… - Science …, 2019 - science.org
Diseases that lead to blood-brain barrier (BBB) disruption will pathologically expose
normally inaccessible brain extracellular matrix (ECM) to circulating blood components …

Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells

M Zorniak, PA Clark, BJ Umlauf, Y Cho, EV Shusta… - Scientific reports, 2017 - nature.com
Glioblastoma stem-like cells (GSC) are hypothesized to evade current therapies and cause
tumor recurrence, contributing to poor patient survival. Existing cell surface markers for GSC …

One-pot synthesis of cellobiose from sucrose using sucrose phosphorylase and cellobiose phosphorylase co-displaying Pichia pastoris as a reusable whole-cell …

K Inokuma, K Toyohara, T Hamada, A Kondo… - Scientific Reports, 2024 - nature.com
Cellobiose has received increasing attention in various industrial sectors, ranging from food
and feed to cosmetics. The development of large-scale cellobiose applications requires a …

Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein

P Heinzelman, PA Romero - PLoS One, 2021 - journals.plos.org
Understanding how human ACE2 genetic variants differ in their recognition by SARS-CoV-2
can facilitate the leveraging of ACE2 as an axis for treating and preventing COVID-19. In this …

Determination of binding affinity upon mutation for type I dockerin–cohesin complexes from Clostridium thermocellum and Clostridium cellulolyticum using deep …

CA Kowalsky, TA Whitehead - Proteins: Structure, Function, and …, 2016 - Wiley Online Library
The comprehensive sequence determinants of binding affinity for type I cohesin toward
dockerin from Clostridium thermocellum and Clostridium cellulolyticum was evaluated using …